Login / Signup

Efficacy and Safety of Lianhua Qingke Tablets in the Treatment of Mild and Common-Type COVID-19: A Randomized, Controlled, Multicenter Clinical Study.

Ling ZhangLei WuXiaolong XuYa-Dong YuanRongmeng JiangXixin YanXin ZhangYong GaoHuanxia ShangBo LianJing HuJianqiang MeiShucai WuQingquan Liu
Published in: Evidence-based complementary and alternative medicine : eCAM (2022)
These preliminary findings indicate LH tablets may be effective in symptomatic COVID-19, especially in relieving coughing. This trial was registered in Chinese Clinical Trial Registry (ChiCTR2100042069).
Keyphrases
  • coronavirus disease
  • clinical trial
  • sars cov
  • double blind
  • phase ii
  • phase iii
  • study protocol
  • open label
  • respiratory syndrome coronavirus
  • randomized controlled trial
  • cross sectional